Systematic review identifies impact of comorbidities on mortality in minimally invasive mitral surgery, suggesting vital implications for surgical outcomes.
Key Points
Postoperative mortality is linked to comorbidities such as chronic kidney disease and diabetes mellitus.
Patients with arterial hypertension showed a significantly increased risk of mortality during and after surgery.
Minimally invasive mitral valve surgery demonstrates favorable outcomes, particularly in echocardiographic measurements.
About 92% of patients exhibited no signs of mitral regurgitation post-surgery, indicating successful interventions.